Thrombolytic therapy

Mickey S. Eisenberg, Richard V. Aghababian, Leo Bossaert, Allan S Jaffe, Joseph P. Ornato, W. Douglas Weaver

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

All patients with symptoms and ECG findings suggestive of acute myocardial infarction (AMI) should be considered for treatment with thrombolytic agents. The decision to use thrombolytic therapy is a clinical judgment based upon a weighing of the potential benefits versus the possible risks. The physician must take into account relative contraindications, age of the patient, area of jeopardized myocardium, and duration of symptoms. Health professionals involved in the care of AMI patients should develop written plans and protocols addressing the following matters: identification of patients with chest pain in the prehospital setting (this applies to hospitals that receive patients from emergency medical services systems), triage of patients in the emergency department, obtaining the 12-lead electrocardiogram, determination of contraindications, authority for ordering thrombolytic therapy, and consultation for atypical cases. There also should be agreed standards for the time interval from arrival in the ED to administration of the thrombolytic agent, as well as a commitment to the prospective monitoring of procedures and times to assure continuous improvement. A time interval for treatment (arrival in ED to administration of drug) of 30 to 60 minutes should be achievable for patients who present with typical symptoms and ECG findings.

Original languageEnglish (US)
Pages (from-to)417-427
Number of pages11
JournalAnnals of Emergency Medicine
Volume22
Issue number2 PART 2
DOIs
StatePublished - 1993
Externally publishedYes

Fingerprint

Thrombolytic Therapy
Electrocardiography
Fibrinolytic Agents
Myocardial Infarction
Triage
Emergency Medical Services
Chest Pain
Hospital Emergency Service
Myocardium
Referral and Consultation
Physicians
Health
Therapeutics
Pharmaceutical Preparations

Keywords

  • acute myocardial infarction
  • thrombolytic therapy

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Eisenberg, M. S., Aghababian, R. V., Bossaert, L., Jaffe, A. S., Ornato, J. P., & Douglas Weaver, W. (1993). Thrombolytic therapy. Annals of Emergency Medicine, 22(2 PART 2), 417-427. https://doi.org/10.1016/S0196-0644(05)80473-1

Thrombolytic therapy. / Eisenberg, Mickey S.; Aghababian, Richard V.; Bossaert, Leo; Jaffe, Allan S; Ornato, Joseph P.; Douglas Weaver, W.

In: Annals of Emergency Medicine, Vol. 22, No. 2 PART 2, 1993, p. 417-427.

Research output: Contribution to journalArticle

Eisenberg, MS, Aghababian, RV, Bossaert, L, Jaffe, AS, Ornato, JP & Douglas Weaver, W 1993, 'Thrombolytic therapy', Annals of Emergency Medicine, vol. 22, no. 2 PART 2, pp. 417-427. https://doi.org/10.1016/S0196-0644(05)80473-1
Eisenberg MS, Aghababian RV, Bossaert L, Jaffe AS, Ornato JP, Douglas Weaver W. Thrombolytic therapy. Annals of Emergency Medicine. 1993;22(2 PART 2):417-427. https://doi.org/10.1016/S0196-0644(05)80473-1
Eisenberg, Mickey S. ; Aghababian, Richard V. ; Bossaert, Leo ; Jaffe, Allan S ; Ornato, Joseph P. ; Douglas Weaver, W. / Thrombolytic therapy. In: Annals of Emergency Medicine. 1993 ; Vol. 22, No. 2 PART 2. pp. 417-427.
@article{47850a01166547e9aff707b3f2724f24,
title = "Thrombolytic therapy",
abstract = "All patients with symptoms and ECG findings suggestive of acute myocardial infarction (AMI) should be considered for treatment with thrombolytic agents. The decision to use thrombolytic therapy is a clinical judgment based upon a weighing of the potential benefits versus the possible risks. The physician must take into account relative contraindications, age of the patient, area of jeopardized myocardium, and duration of symptoms. Health professionals involved in the care of AMI patients should develop written plans and protocols addressing the following matters: identification of patients with chest pain in the prehospital setting (this applies to hospitals that receive patients from emergency medical services systems), triage of patients in the emergency department, obtaining the 12-lead electrocardiogram, determination of contraindications, authority for ordering thrombolytic therapy, and consultation for atypical cases. There also should be agreed standards for the time interval from arrival in the ED to administration of the thrombolytic agent, as well as a commitment to the prospective monitoring of procedures and times to assure continuous improvement. A time interval for treatment (arrival in ED to administration of drug) of 30 to 60 minutes should be achievable for patients who present with typical symptoms and ECG findings.",
keywords = "acute myocardial infarction, thrombolytic therapy",
author = "Eisenberg, {Mickey S.} and Aghababian, {Richard V.} and Leo Bossaert and Jaffe, {Allan S} and Ornato, {Joseph P.} and {Douglas Weaver}, W.",
year = "1993",
doi = "10.1016/S0196-0644(05)80473-1",
language = "English (US)",
volume = "22",
pages = "417--427",
journal = "Annals of Emergency Medicine",
issn = "0196-0644",
publisher = "Mosby Inc.",
number = "2 PART 2",

}

TY - JOUR

T1 - Thrombolytic therapy

AU - Eisenberg, Mickey S.

AU - Aghababian, Richard V.

AU - Bossaert, Leo

AU - Jaffe, Allan S

AU - Ornato, Joseph P.

AU - Douglas Weaver, W.

PY - 1993

Y1 - 1993

N2 - All patients with symptoms and ECG findings suggestive of acute myocardial infarction (AMI) should be considered for treatment with thrombolytic agents. The decision to use thrombolytic therapy is a clinical judgment based upon a weighing of the potential benefits versus the possible risks. The physician must take into account relative contraindications, age of the patient, area of jeopardized myocardium, and duration of symptoms. Health professionals involved in the care of AMI patients should develop written plans and protocols addressing the following matters: identification of patients with chest pain in the prehospital setting (this applies to hospitals that receive patients from emergency medical services systems), triage of patients in the emergency department, obtaining the 12-lead electrocardiogram, determination of contraindications, authority for ordering thrombolytic therapy, and consultation for atypical cases. There also should be agreed standards for the time interval from arrival in the ED to administration of the thrombolytic agent, as well as a commitment to the prospective monitoring of procedures and times to assure continuous improvement. A time interval for treatment (arrival in ED to administration of drug) of 30 to 60 minutes should be achievable for patients who present with typical symptoms and ECG findings.

AB - All patients with symptoms and ECG findings suggestive of acute myocardial infarction (AMI) should be considered for treatment with thrombolytic agents. The decision to use thrombolytic therapy is a clinical judgment based upon a weighing of the potential benefits versus the possible risks. The physician must take into account relative contraindications, age of the patient, area of jeopardized myocardium, and duration of symptoms. Health professionals involved in the care of AMI patients should develop written plans and protocols addressing the following matters: identification of patients with chest pain in the prehospital setting (this applies to hospitals that receive patients from emergency medical services systems), triage of patients in the emergency department, obtaining the 12-lead electrocardiogram, determination of contraindications, authority for ordering thrombolytic therapy, and consultation for atypical cases. There also should be agreed standards for the time interval from arrival in the ED to administration of the thrombolytic agent, as well as a commitment to the prospective monitoring of procedures and times to assure continuous improvement. A time interval for treatment (arrival in ED to administration of drug) of 30 to 60 minutes should be achievable for patients who present with typical symptoms and ECG findings.

KW - acute myocardial infarction

KW - thrombolytic therapy

UR - http://www.scopus.com/inward/record.url?scp=0027465140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027465140&partnerID=8YFLogxK

U2 - 10.1016/S0196-0644(05)80473-1

DO - 10.1016/S0196-0644(05)80473-1

M3 - Article

C2 - 8434841

AN - SCOPUS:0027465140

VL - 22

SP - 417

EP - 427

JO - Annals of Emergency Medicine

JF - Annals of Emergency Medicine

SN - 0196-0644

IS - 2 PART 2

ER -